Yitzhak Peterburg, who previously served as Teva Pharmaceuticals’ chairman and interim chief executive, on Tuesday resigned from the company’s board effective immediately, Reuters reported.
The debt-laden Israeli drugmaker has witnessed a series of changes in recent months after CEO Kare Schultz, who joined Teva on November 1, ousted top division heads and rolled out a plan to streamline operations.